MedTrace Logo

Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)

NCT06896617 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 334

Last updated 2025-04-02

No results posted yet for this study

Summary

In pregnancies achieved through programmed frozen embryo transfer cycle (PC-FET) and modified natural frozen embryo transfer (mNC-FET), to determine whether there are differences in endothelial and placental function, maternal cardiovascular function, fetal growth and fetal cardiovascular and cerebral programming and to assess whether there is an association between these differences and the plasma concentrations of the main secretion products of the Corpus Luteum (CL) with vasoactive and angiogenic action.

Conditions

  • Infertilities
  • Embryo Transfer

Interventions

DRUG

Estradiol + Progesterone

Pregnancies with absence of corpus luteum(PC-FET)

DRUG

Ovitrelle ( Hcg 250 mcg)

NC-FET(natural cycle FET, endometrial preparation with presence of CL)

Sponsors & Collaborators

  • Fundacion Clinic per a la Recerca Biomédica

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
41 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-01
Primary Completion
2026-11-20
Completion
2026-12-20

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06896617 on ClinicalTrials.gov